Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulus

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Harvey, Lauren E ^a   Kohlgraf, Karl G ^a   Mehalick, Leslie A ^a   Raina, Monica ^a   Recker, Erica N ^a   Radhakrishnan, Saumya ^b   Prasad, Samiksha Avinash ^b   Vidva, Robinson ^b   Progulske Fox, Ann ^c   Cavanaugh, Joseph E ^d   Vali, Shireen ^b,e   Brogden, Kim A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b Cellworks Research India Pvt Ltd   (India)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e CELLWORKS GROUP INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BETA DEFENSIN; BETA DEFENSIN 3, HUMAN; BETA-DEFENSIN 3, HUMAN; CHEMOKINE; COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; CYTOKINE; HAGB PROTEIN, PORPHYROMONAS GINGIVALIS; LECTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; C57BL MOUSE; DENDRITIC CELL; DRUG EFFECT; HUMAN; METABOLISM; MOUSE; PORPHYROMONAS GINGIVALIS;

ADHESINS, BACTERIAL; ANIMALS; BETA-DEFENSINS; CHEMOKINE CXCL1; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; HUMANS; LECTINS; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; PORPHYROMONAS GINGIVALIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873689768     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01232     Document Type: Article

References (40)

1. Harder, J., Bartels, J., Christophers, E. & Schroder, J. M. Isolation and characterization of human b-Defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713 (2001).
2. Tao, R. et al. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob. Agents Chemother. 49, 3883-3888 (2005).
3. Dommisch, H., Acil, Y., Dunsche, A., Winter, J. & Jepsen, S. Differential gene expression of human beta-defensins (hBD-1,-2,-3) in inflammatory gingival diseases. Oral Microbiol. Immunol. 20, 186-190 (2005).
4. Zilbauer, M. et al. Expression of human beta-defensins in children with chronic inflammatory bowel disease. PLoS One 5, e15389 (2010).
5. Kesting, M. R. et al. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest. 27, 575-581 (2009).
6. Frasca, L. & Lande, R. Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases. Curr. Pharm. Biotechnol. 13, 1882-1897 (2012).
7. Lippross, S. et al. Multiple trauma induces serum production of host defence peptides. Injury 43, 137-142 (2012).
8. Jin, G. et al. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5, e10993 (2010).
9. Boniotto, M. et al. Human b-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 50, 1433-1441 (2006).
10. Niyonsaba, F. et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127, 594-604 (2007).
11. Presicce, P., Giannelli, S., Taddeo, A., Villa, M. L. & Della Bella, S. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J. Leuk. Biol. 86, 941-948 (2009).
12. Semple, F. et al. Human b-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur. J. Immunol. 41, 3291-3300 (2011).
13. Semple, F. et al.Human b-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur. J. Immunol. 40, 1073-1078 (2010).
14. Shi, J. et al. A novel role for defensins in intestinal homeostasis: regulation of IL-1b secretion. J. Immunol. 179, 1245-1253 (2007).
15. Miles, K. et al.Dying and necrotic neutrophils are anti-inflammatory secondary to the release of a-defensins. J. Immunol. 183, 2122-2132 (2009).
16. Pingel, L. C. et al. Human b-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol. Cell Biol. 86, 643-649 (2008).
17. Dietrich, D. E. et al. Human a-and b-defensins bind to immobilized adhesins from Porphyromonas gingivalis. Infect. Immun. 76, 5714-5720 (2008).
18. Gallo, S. A. et al. Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J. Biol. Chem. 281, 18787-18792 (2006).
19. Wei, G. et al. Through the looking glass, mechanistic insights from enantiomeric human defensins. J. Biol. Chem. 284, 29180-29192 (2009).
20. Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12, 503-516 (2012).
21. Van Hemert, J. R. et al. Human b-defensin-3 alters, but does not inhibit, the binding of Porphyromonas gingivalis haemagglutinin B to the surface of human dendritic cells. Int. J. Antimicrob. Agents. 40, 75-79 (2012).
22. Semple, F. & Dorin, J. R. b-Defensins: Multifunctional Modulators of Infection, Inflammation and More? J. Innate Immun. 4, 337-348 (2012).
23. Gaddis, D. E., Michalek, S. M. & Katz, J. TLR4 signaling via MyD88 and TRIF differentially shape the CD41 T cell response to Porphyromonas gingivalis hemagglutinin B. J. Immunol. 186, 5772-5783 (2011).
24. Vali, S., Pallavi, R., Kapoor, S. & Tatu, U. Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotype. Syst. Synth. Biol. 4, 25-33 (2010).
25. Rajendran, P. et al. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin. Cancer Res. 17, 1425-1439 (2011).
26. Equils, O. et al. A computer simulation of progesterone and Cox2 inhibitor treatment for preterm labor. PLoS One 5, e8502 (2010).
27. Barve, A. et al. A kinetic platform for in silico modeling of themetabolic dynamics in Escherichia coli. Adv. Appl. Bioinform. Chem. 3, 97-110 (2010).
28. Sultana, Z. et al. Dynamic modeling of alpha-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy. Neuroscience 199, 303-317 (2011).
29. Roy, K. R. et al. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line. Cancer Chemother. Pharmacol. 65, 903-911 (2010).
30. Ao, X. et al. Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J. Hematol. Oncol. 2, 6 (2009).
31. Awasthi, S., Brown, K., King, C., Awasthi, V. & Bondugula, R. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-a release from mouse JAWS II dendritic cells. J. Pharmacol. Exp. Ther. 336, 672-681 (2011).
32. Gorr, S. U. Antimicrobial peptides of the oral cavity. Periodontology 2000 51, 152-180 (2009).
33. Gorr, S. U. & Abdolhosseini, M. Antimicrobial peptides and periodontal disease. J. Clin. Periodontol. 38 Suppl 11, 126-141 (2011).
34. Hooper, S. J. et al. Viable bacteria present within oral squamous cell carcinoma tissue. J. Clin. Microbiol. 44, 1719-1725 (2006).
35. Kohlgraf, K. G. et al.Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice. Future Microbiol 5, 115-125 (2010).
36. Rohrl, J., Yang, D., Oppenheim, J. J. & Hehlgans, T. Identification and biological characterization of mouse b-defensin 14, the orthologue of human b2defensin 3. J. Biol. Chem. 283, 5414-5419 (2008).
37. Roop, R. M. 2nd et al. Brucella stationary-phase gene expression and virulence. Annu. Rev. Microbiol. 57, 57-76 (2003).
38. Hinrichsen, K. et al.Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother 52, 1876-1879 (2008).
39. Taylor, K. et al. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of b-defensin 3. J. Biol. Chem. 283, 6631-6639 (2008).
40. Seal, R. L., Gordon, S. M., Lush, M. J., Wright, M. W. & Bruford, E. A. genenames.org: the HGNC resources in 2011. Nucleic. Acids. Res. 39, D514-519 (2011).